Beacon raises $170M to take on J&J in ocular gene therapy

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

American Heart Association invests in the future of heart and brain health research

More than 100 scientists from across the U.S. are receiving special grants to support their research work in finding innovative solutions to fight heart disease

July 21, 2023

How a scientific slip-up caused a pregnant woman to get an untested treatment for preterm birth

Makena, once the only available treatment to prevent preterm birth, has had its share of controversy. A yearslong debate over the drug’s effectiveness led the

April 22, 2024

Europe lines up first CRISPR therapy approval

Following FDA approval, Vertex Pharmaceuticals and CRISPR Therapeutics on Friday received a positive recommendation for a conditional approval by a key European medicines panel for

December 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.